Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Amortization - Intangibles (2017 - 2025)

Adma Biologics (ADMA) has disclosed Amortization - Intangibles for 9 consecutive years, with $51000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Amortization - Intangibles rose 104.0% year-over-year to $51000.0, compared with a TTM value of $144000.0 through Dec 2025, down 65.96%, and an annual FY2025 reading of $144000.0, down 62.89% over the prior year.
  • Amortization - Intangibles was $51000.0 for Q4 2025 at Adma Biologics, up from $36000.0 in the prior quarter.
  • Across five years, Amortization - Intangibles topped out at $200000.0 in Q1 2021 and bottomed at $25000.0 in Q4 2024.
  • Average Amortization - Intangibles over 5 years is $136666.2, with a median of $178838.0 recorded in 2021.
  • Peak annual rise in Amortization - Intangibles hit 104.0% in 2025, while the deepest fall reached 87.05% in 2025.
  • Year by year, Amortization - Intangibles stood at $200000.0 in 2021, then plummeted by 39.42% to $121162.0 in 2022, then surged by 54.34% to $187000.0 in 2023, then tumbled by 86.63% to $25000.0 in 2024, then surged by 104.0% to $51000.0 in 2025.
  • Business Quant data shows Amortization - Intangibles for ADMA at $51000.0 in Q4 2025, $36000.0 in Q3 2025, and $32000.0 in Q2 2025.